• Poster

Cost-effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the UK

Citation

Wolowacz, S. E., Brockbank, J. A., Gonschior, A., & Sunderland, T. (2013, November). Cost-effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the UK. Presented at ISPOR 16th Annual European Congress, .

Abstract